Literature DB >> 32732090

Significance of multifocality in papillary thyroid carcinoma.

Jia-Wei Feng1, Zhen Qu1, An-Cheng Qin2, Hua Pan1, Jing Ye3, Yong Jiang4.   

Abstract

BACKGROUND: Although multifocality is often observed in papillary thyroid carcinoma (PTC), the associations with clinicopathologic factors and the prognostic value are still controversial. We aimed to identify the risk factors for multifocality and bilaterality, and investigate the significance of multifocality on prognosis in all PTC, papillary thyroid microcarcinoma (PTMC) and non-PTMC.
METHODS: Data from 635 patients who underwent lobectomy/total thyroidectomy plus cervical lymph node dissection for PTC were retrospectively analyzed. Clinicopathological factors associated with multifocal PTC and bilateral PTC were investigated by univariate analysis. Multivariate Cox regression analyses was used to identify the clinicopathological prognostic factors for recurrence-free survival.
RESULTS: Multifocal and bilateral PTC were observed in 157 (24.7%) and 99 (15.6%) patients, respectively. The frequency of large diameter (>1.0 cm), extrathyroidal extension (ETE), vascular invasion and central lymph node metastases (CLNM) was higher in multifocal PTC than that of solitary PTC. Moreover, ETE, vascular invasion, CLNM and lateral lymph node metastasis (LLNM) were more frequent in patients with 3 or more tumor foci compared to those with 2 tumor foci and 1 tumor lesion. Bilateral PTC had higher rates of ETE and CLNM. Multifocality was found to be the predictor of recurrence in all PTC, PTMC, and non-PTMC. In addition, the risk of recurrence increased with increasing number of tumor foci in all multifocal PTC patients and multifocal non-PTMC patients.
CONCLUSION: Although multifocality and bilaterality had more aggressive features in PTC, only multifocality was associated with the increased risk of recurrence. An increase in the number of tumors was associated with an increased risk of ETE, vascular invasion, CLNM and LLNM. The prognostic value of multifocality is particularly significant in non-PTMC patients.
Copyright © 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Bilaterality; Multifocality; Papillary thyroid carcinoma; Papillary thyroid microcarcinoma; Recurrence-free survival

Year:  2020        PMID: 32732090     DOI: 10.1016/j.ejso.2020.06.015

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  11 in total

1.  Analysis of Risk Factors Associated With Central Lymph Node Metastasis in Papillary Thyroid Carcinoma With cT1N0 Stage.

Authors:  Yin-Zhu Zhao; Nian-An He; Xian-Jun Ye; Fu Jin; Meng-Xue Li; Xianxian Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-03       Impact factor: 6.055

Review 2.  [Hemithyroidectomy or total thyroidectomy for low-risk papillary thyroid cancer? : Surgical criteria for primary and secondary choice of treatment in an interdisciplinary treatment concept].

Authors:  H Dralle; F Weber; A Machens; T Brandenburg; K W Schmid; D Führer-Sakel
Journal:  Chirurgie (Heidelb)       Date:  2022-09-19

3.  Real-Time Elastography: A Web-Based Nomogram Improves the Preoperative Prediction of Central Lymph Node Metastasis in cN0 PTC.

Authors:  Chunwang Huang; Wenxiao Yan; Shumei Zhang; Yanping Wu; Hantao Guo; Kunming Liang; Wuzheng Xia; Shuzhen Cong
Journal:  Front Oncol       Date:  2022-01-13       Impact factor: 6.244

4.  Therapeutic Strategy in Low-Risk Papillary Thyroid Carcinoma - Long-Term Results of the First Single-Center Prospective Non-Randomized Trial Between 2011 and 2015.

Authors:  Agnieszka Czarniecka; Marcin Zeman; Grzegorz Wozniak; Adam Maciejewski; Ewa Stobiecka; Ewa Chmielik; Malgorzata Oczko-Wojciechowska; Jolanta Krajewska; Daria Handkiewicz-Junak; Barbara Jarzab
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-06       Impact factor: 5.555

5.  Multifocality in patients treated for papillary Thyroid Carcinoma: a preliminary analysis of related risk factors.

Authors:  Paolo Del Rio; Tommaso Loderer; Mario Giuffrida; Federico Cozzani; Matteo Rossini; Deborah Bonfili; Elena Bonati
Journal:  Acta Biomed       Date:  2021-11-03

6.  Predictive Factors for Recurrence of Papillary Thyroid Carcinoma in Children and Adolescents.

Authors:  Yan Gui; Dongmei Huang; Yun Hou; Xudong Wei; Jinming Zhang; Junyi Wang
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

7.  Total tumor diameter is a better indicator of multifocal papillary thyroid microcarcinoma: A propensity score matching analysis.

Authors:  Ke-Cheng Jiang; Bei Lin; Yu Zhang; Ling-Qian Zhao; Ding-Cun Luo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-08       Impact factor: 6.055

8.  Number of Tumor Foci as a Risk Factor for Recurrence in Papillary Thyroid Carcinoma: Does It Improve Predictability?

Authors:  Hyungju Kwon; Woosung Lim; Byung-In Moon
Journal:  Cancers (Basel)       Date:  2022-08-26       Impact factor: 6.575

9.  Risk Factors and Prediction Model for Lateral Lymph Node Metastasis of Papillary Thyroid Carcinoma in Children and Adolescents.

Authors:  Weili Liang; Lei Sheng; Liguang Zhou; Changyuan Ding; Zhongyang Yao; Chao Gao; Qingdong Zeng; Bo Chen
Journal:  Cancer Manag Res       Date:  2021-02-16       Impact factor: 3.989

10.  Risk Factors for Contralateral Occult Carcinoma in Patients With Unilateral Papillary Thyroid Carcinoma: A Retrospective Study and Meta-Analysis.

Authors:  Fan Zhang; Boyuan Zheng; Xiaohui Yu; Xichang Wang; Shiwei Wang; Weiping Teng
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-12       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.